scholarly article | Q13442814 |
P356 | DOI | 10.1164/AJRCCM.149.3.8118632 |
P698 | PubMed publication ID | 8118632 |
P2093 | author name string | Semenzato G | |
Meloni F | |||
Car BD | |||
Walz A | |||
Luisetti M | |||
Gialdroni-Grassi G | |||
P433 | issue | 3 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pulmonary fibrosis | Q32446 |
patient | Q181600 | ||
bronchoalveolar lavage | Q927148 | ||
idiopathic pulmonary fibrosis | Q2290446 | ||
P304 | page(s) | 655-659 | |
P577 | publication date | 1994-03-01 | |
P1433 | published in | American Journal of Respiratory and Critical Care Medicine | Q4744267 |
P1476 | title | Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis | |
P478 | volume | 149 |
Q64066307 | A SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis |
Q24811760 | A role for MCP-1/CCR2 in interstitial lung disease in children. |
Q41869210 | Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV1 in COPD patients |
Q34243627 | Alveolar macrophage-T cell interactions during Th1-type sarcoid inflammation |
Q40691073 | Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-kappa b-dependent signaling pathways |
Q34964361 | Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavage |
Q36643353 | Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours |
Q44497452 | Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice |
Q24796466 | Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2 |
Q35372594 | Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis |
Q35834281 | Bovine ENA, a new monocyte-macrophage derived cytokine of the interleukin-8 family. Structure, function, and expression in acute pulmonary inflammation |
Q77807407 | Bradykinin stimulates interleukin-8 production by human lung fibroblasts |
Q47256226 | CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia |
Q61447595 | Cells and molecules involved in the development of sarcoid granuloma |
Q35942991 | Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells. |
Q38057375 | Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside. |
Q35786037 | Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition |
Q42113310 | Concomitant pemphigus herpetiformis and sarcoidosis |
Q74404688 | Correlation of plasma monocyte chemoattractant protein-1 (MCP-1) and monocyte inflammatory protein-1alpha (MIP-1alpha) levels with disease activity and clinical course of sarcoidosis |
Q73702562 | Delayed clearance of zymosan-induced granuloma and depressed phagocytosis of macrophages with concomitant up-regulated kinase activities of Src-family in a human monocyte chemoattractant protein-1 transgenic mouse |
Q37594222 | Determinants of initiation and progression of idiopathic pulmonary fibrosis |
Q98196787 | Development of a miniaturized 96-Transwell air-liquid interface human small airway epithelial model |
Q51689652 | Differential role for T cells in the development of fibrotic lesions associated with reovirus 1/L-induced bronchiolitis obliterans organizing pneumonia versus Acute Respiratory Distress Syndrome. |
Q80597495 | Dual-immunohistochemistry provides little evidence for epithelial-mesenchymal transition in pulmonary fibrosis |
Q70988167 | Effects of 3'-hydroxyfarrerol (IdB 1031), a novel flavonoid agent, on phagocyte products |
Q43293567 | Effects of IS-741, a synthetic anti-inflammatory agent, on bleomycin-induced lung injury in mice |
Q71292009 | Elevated interleukin-8 in the alveolitis of individuals with asbestos exposure |
Q42068942 | Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients |
Q38305959 | Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation |
Q37351580 | Epithelial-macrophage interactions determine pulmonary fibrosis susceptibility in Hermansky-Pudlak syndrome |
Q57810775 | Fucoidan Inhibits Radiation-Induced Pneumonitis and Lung Fibrosis by Reducing Inflammatory Cytokine Expression in Lung Tissues |
Q35532901 | Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis |
Q26863703 | Granuloma formation in pulmonary sarcoidosis |
Q51642627 | Helper T-lymphocyte-related chemokines in healthy newborns. |
Q45962309 | Human neutrophils switch to an activated phenotype after homing to the lung irrespective of inflammatory disease. |
Q42480005 | IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8. |
Q50241267 | IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity |
Q34105088 | Immune mechanisms in interstitial lung diseases. |
Q30432636 | Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis |
Q41529645 | Immunological, clinical and molecular aspects of sarcoidosis. |
Q41079018 | In vivo, in vitro, and molecular aspects of interleukin-8 and the interleukin-8 receptors |
Q51711077 | Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage. |
Q41164322 | Induction of interleukin-1 and interleukin-8 mRNAs and proteins by TGF beta 1 in rat lung alveolar epithelial cells |
Q45883325 | Infection of replication-deficient adenoviral vector enhances interleukin-8 production in small airway epithelial cells more than in large airway epithelial cells |
Q41090418 | Inflammatory mediators, cytokines, and adhesion molecules in pulmonary inflammation and injury. |
Q35066461 | Inflammatory profile and response to anti-tumor necrosis factor therapy in patients with chronic pulmonary sarcoidosis |
Q89947669 | Inhalation of lung spheroid cell secretome and exosomes promotes lung repair in pulmonary fibrosis |
Q51656775 | Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis. |
Q49241236 | Interactions of P 1507, a new antioxidant agent, with phagocyte functions. |
Q89338769 | Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice |
Q48003715 | Interleukin-8 expression in bronchoalveolar lavage cells in the evaluation of alveolitis in idiopathic pulmonary fibrosis. |
Q80839683 | Interstitial lung disease in systemic sclerosis |
Q37742646 | Investigational approaches to therapies for idiopathic pulmonary fibrosis |
Q46706475 | Involvement of discoidin domain receptor 1 in the deterioration of pulmonary sarcoidosis |
Q42251801 | Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells. |
Q42501723 | Keratinocyte chemoattractant (interleukin-8) regulation of sinonasal cilia function in a murine model |
Q42479824 | Keratinocyte-Derived Monocyte Chemoattractant Protein 1 (MCP-1): Analysis in a Transgenic Model Demonstrates MCP-1 Can Recruit Dendritic and Langerhans Cells to Skin |
Q89076747 | Lung Defense through IL-8 Carries a Cost of Chronic Lung Remodeling and Impaired Function |
Q33905052 | Lymphatics in idiopathic pulmonary fibrosis: new insights into an old disease |
Q34560457 | Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis |
Q37137670 | Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells |
Q42099223 | Macrophage-derived biomarkers of idiopathic pulmonary fibrosis |
Q47132756 | Mesenchymal Stem Cell Soluble Mediators and Cystic Fibrosis |
Q34426098 | Modulation of lung inflammation by the Epstein-Barr virus protein Zta |
Q28390078 | Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review |
Q38220769 | Molecular biomarkers in interstitial lung diseases. |
Q37109532 | Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo |
Q43246754 | Multiplex protein profiling of bronchoalveolar lavage in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis |
Q43111567 | N-acetylcysteine inhibits IL-8 and MMP-9 release and ICAM-1 expression by bronchoalveolar cells from interstitial lung disease patients |
Q37585596 | Non-invasive biomarkers in pulmonary fibrosis |
Q74258773 | Occupational lung disease |
Q30332571 | Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases. |
Q44012128 | Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells |
Q37722606 | Plasmodium genetic loci linked to host cytokine and chemokine responses |
Q44997658 | Protein kinase Cdelta mediates lysophosphatidic acid-induced NF-kappaB activation and interleukin-8 secretion in human bronchial epithelial cells |
Q36244231 | Pulmonary fibrosis |
Q28388425 | Pulmonary fibrosis: pathogenesis, etiology and regulation |
Q40561722 | Relationship between myeloperoxidase promotor polymorphism and disease severity in sarcoidosis. |
Q39410233 | Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis |
Q35792214 | Respiratory Reovirus 1/L Induction of Intraluminal Fibrosis, a Model of Bronchiolitis Obliterans Organizing Pneumonia, Is Dependent on T Lymphocytes |
Q38658788 | Respiratory effects of sulfur mustard exposure, similarities and differences with asthma and COPD. |
Q34302935 | Role of bronchoalveolar lavage in interstitial lung disease |
Q42789370 | Role of interferon-gamma in interleukin 12-induced pathology in mice. |
Q48003748 | Sarcoidosis: historical perspective and immunopathogenesis (Part I). |
Q24815010 | Serum biomarkers in interstitial lung diseases |
Q47443642 | The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants |
Q41743838 | The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease |
Q35067114 | The cytokine network in sarcoidosis and its clinical relevance |
Q71615839 | The inhibitory effect of pentamidine on the production of chemotactic cytokines by in vitro stimulated human blood cells |
Q71548621 | The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells |
Q38290539 | The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis |
Q37800756 | The pathogenesis of idiopathic pulmonary fibrosis. |
Q28393864 | The role of PPARγ in carbon nanotube-elicited granulomatous lung inflammation |
Q36981609 | The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis |
Q97568944 | Therapeutic targeting of 15-PGDH in murine pulmonary fibrosis |
Q73500736 | To clot or not to clot, that is the question in pulmonary fibrosis |
Q38287405 | Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration |
Search more.